Sign in

or Register now

MyRACentral.com

    See all of our health sites at www.HealthCentral.com
    Sunday, November 22, 2009
    • Font size
    • Bookmark
    • Save
    Receive a FREE Osteoarthritis of the knee pamphlet.  Start here.

    New RA drug moves forward despite failed trial

    (Reuters) UPDATED 2009-11-03
    Drugmaker Rigel Pharmaceuticals is reporting that it will move forward with late-stage clinical trials for a new drug for rheumatoid arthritis (RA), even though the drug failed to meet its goals in a mid-stage trial. The drug--currently called R788--failed to perform as well as expected against a placebo in the recent trial. The late-stage trial will begin in the first half of 2010.  Read full story >
    See all Rheumatoid Arthritis News
    • Font size
    • Bookmark
    • Was this helpful? Yes
    • Save

    People who read this also read...

      Note: All clinical content on this site is physician-reviewed, except material generated by our community members.
      Featuring Content From:
      • Harvard Health Publications
      • A.D.A.M.
      • Thomson PDR
      • Ivanhoe Broadcast News

      By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyRACentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

      This website is accredited by Health On the Net Foundation. Click to verify.We comply with the HONcode standard for trustworthy health information: verify here.
      • TRUSTe Certified Privacy
      • Health Care Standard of Excellence
      • FREDDIE International Health and Medical Media Award Finalist